A Sensible Decision: Evidence Should Guide Management Decisions for Asymptomatic WPW Pattern in Any Patient

por Klein, George J., Gula, Lorne J.
Publicado 2022

Safety of Lead Repair Compared to Lead Revision for Visible Lead Insulation Defects in Patients With Cardiac Implantable Electronic Devices

por Fanous, Yehia, Gula, Lorne, Skanes, Allan, Tang, Anthony, Yee, Raymond, Khan, Habib R.
Publicado 2021

Syncope: Review of Monitoring Modalities

por Subbiah, Rajesh, Gula, Lorne J, Klein, George J, Skanes, Allan C, Yee, Raymond, Krahn, Andrew D
Publicado 2008

Cardiac Monitoring in Patients with Syncope: Making that Elusive Diagnosis

por Subbiah, Rajesh, Chia, Pow-Li, Gula, Lorne J., Klein, George J., Skanes, Allan C., Yee, Raymond, Krahn, Andrew D.
Publicado 2013

Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure

por Manlucu, Jaimie, Sharma, Vinod, Koehler, Jodi, Warman, Eduardo N., Wells, George A., Gula, Lorne J., Yee, Raymond, Tang, Anthony S.
Publicado 2019

Clinical feasibility of targeted cardiac resynchronization lead delivery using a 3D MRI cardiac model

por Stirrat, John, Yee, Raymond, Krahn, Andrew, Gula, Lorne J, Leong-Sit, Peter, Klein, George J, Scholl, David, Goela, Aashish, Drangova, Maria, White, James A
Publicado 2012

Predictors of response to cardiac resynchronization therapy on pre-implantation cardiovascular magnetic resonance imaging

por Manian, Usha, Yee, Raymond, Nevis, Immaculate, McCarty, David, Stirrat, John, Scholl, David, Gula, Lorne J, Leong-Sit, Peter, Drangova, Maria, White, James A
Publicado 2013

Delayed enhancement cardiac magnetic resonance imaging predicts future arrhythmic events in primary prevention ICD candidates irrespective of ischemic or non-ischemic etiology

por Gao, Peng, Yee, Raymond, Hogg, Ellie, Stirrat, John, Scholl, David, Gula, Lorne, Krahn, Andrew D, Skanes, Allan, Leong-Sit, Peter, Klein, George, White, James A
Publicado 2011

Evaluating Polygenic Risk Scores in “Lone” Atrial Fibrillation

por Lazarte, Julieta, Dron, Jacqueline S., McIntyre, Adam D., Skanes, Allan C., Gula, Lorne J., Tang, Anthony S., Tadros, Rafik, Laksman, Zachary W., Hegele, Robert A., Roberts, Jason D.
Publicado 2021

Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study

por Qirjazi, Elena, McArthur, Eric, Nash, Danielle M., Dixon, Stephanie N., Weir, Matthew A., Vasudev, Akshya, Jandoc, Racquel, Gula, Lorne J., Oliver, Matthew J., Wald, Ron, Garg, Amit X.
Publicado 2016

Paced segment characteristics predict clinical response to cardiac resynchronization therapy: results from the multimodality imaging assessment of pacing intervention in heart fail...

por Wong, Jorge A, Scholl, David, Yee, Raymond, Stirrat, John, Carter, Kris, McCarty, David, Fine, Nowell, Krahn, Andrew, Gula, Lorne, Skanes, Allan, Leong-Sit, Peter, Klein, George, Drangova, Maria, White, James A
Publicado 2011

A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation

por Orr, Nathan, Arnaout, Rima, Gula, Lorne J., Spears, Danna A., Leong-Sit, Peter, Li, Qiuju, Tarhuni, Wadea, Reischauer, Sven, Chauhan, Vijay S., Borkovich, Matthew, Uppal, Shaheen, Adler, Arnon, Coughlin, Shaun R., Stainier, Didier Y. R., Gollob, Michael H.
Publicado 2016